DOI: 10.1002/cncr.34962 ISSN:

Cannabinoids for symptom management in children with cancer: It’s complicated

Holly L. Spraker‐Perlman, R. Elyse Heidelberg
  • Cancer Research
  • Oncology

Data surrounding the use of cannabinoids for symptom management in children with cancer are heterogeneous and extremely limited. Well‐designed clinical trials with specific indications, products, and outcome metrics are required before cannabinoids should be considered in frontline cancer care in children.

More from our Archive